KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xylem (XYL) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Xylem (XYL) over the last 10 years, with Q3 2025 value amounting to -$37.0 million.

  • Xylem's Other Operating Expenses fell 175000.0% to -$37.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.0 million, marking a year-over-year decrease of 114285.71%. This contributed to the annual value of -$46.0 million for FY2024, which is 450000.0% down from last year.
  • Latest data reveals that Xylem reported Other Operating Expenses of -$37.0 million as of Q3 2025, which was down 175000.0% from -$10.0 million recorded in Q1 2025.
  • Xylem's Other Operating Expenses' 5-year high stood at $2.0 million during Q2 2021, with a 5-year trough of -$40.0 million in Q4 2024.
  • Over the past 5 years, Xylem's median Other Operating Expenses value was -$2.0 million (recorded in 2024), while the average stood at -$10.1 million.
  • In the last 5 years, Xylem's Other Operating Expenses crashed by 390000.0% in 2024 and then plummeted by 10000.0% in 2025.
  • Xylem's Other Operating Expenses (Quarter) stood at $2.0 million in 2021, then tumbled by 50.0% to $1.0 million in 2022, then tumbled by 200.0% to -$1.0 million in 2023, then tumbled by 3900.0% to -$40.0 million in 2024, then increased by 7.5% to -$37.0 million in 2025.
  • Its Other Operating Expenses was -$37.0 million in Q3 2025, compared to -$10.0 million in Q1 2025 and -$40.0 million in Q4 2024.